Research on Llama Antibodies for Disease Diagnosis and Treatment

other · National Research Council Canada, Ottawa

Research by the National Research Council Canada and collaborators is exploring the use of llama-derived single-domain antibodies (nanobodies) for diagnosing and treating diseases such as Alzheimer's. These antibodies can cross the blood-brain barrier and specifically mark cerebral lesions. Human trials are expected to begin in the next few years.

This is the archive, not the newspaper. Between 2018 and 2026 this site compiled these items automatically from public community sources — chiefly The Islands Grapevine, regional news feeds and community groups. They were not written by a reporter and were not held to the standards this publication now applies. The archive is kept because it is a useful dated record of what happened on Denman, and it is labelled because pretending otherwise would be the first thing we would tell you not to trust. Current reporting is at The Denman Firestarter.

Sources

• “Current research being conducted by Dr. Jamshid Tanha's antibody therapeutics group at the National Research Council Canada... Human trials using llama antibodies in Alzheimer's patients are predicted to get underway in the next few years.” — The Islands Grapevine – January 18th, 2024 (January 18th, 2024)

Spotted an error? corrections@denmanisland.co.